A study by Iyoda and colleagues revealed that the activities of p38 MAPK and its upstream MKK6 in HCC were significantly lower than in adjacent non-neoplastic liver tissue, suggesting that the reduction in p38 MAPK activities provides a growth advantage to human HCC, in part by resisting apoptosis [14]. This evidence concerns the gene MAP2K6 and hepatocellular carcinoma.